The UCLA Hematologic Malignancy/Stem Cell Transplantation Program offers diagnostic and treatment services for patients with cancers of the blood and bone marrow. The program offers patients a range of personalized treatment options in both inpatient and outpatient settings, including comprehensive treatment therapies, stem cell transplants and the latest in investigational drugs. To provide patients with a coordinated treatment program, our expert team of physicians meets weekly to discuss and develop personalized treatment plans.
At the UCLA Hematologic Malignancy/Stem Cell Transplantation Program, we strive to:
UCLA Health is proud to be one of the first centers in the nation to be offering this CAR T-cell Therapy. Learn more about CAR T-cell therapy >
UCLA Health has a long history of innovation and landmark accomplishments in stem cell transplantation for patients with hematologic diseases. UCLA Medical Center was one of the first medical centers to perform bone marrow transplantation in 1968. In 1973, the UCLA Bone Marrow Transplantation Program was formally established, and since then, UCLA has performed well over 5,000 transplants (pediatric and adult)
UCLA Health provides stem cell treatment for patients with the following diseases:
Since it was first performed more than 50 years ago, bone marrow transplantation remains a lifesaving treatment option for patients with various types of cancers and non-malignant hematologic disorders. Historically, hematopoietic cell transplantation (HCT) has been performed as an inpatient procedure for patients with leukemia, lymphoma and a variety of hematologic malignancies. At most transplant centers, HCT is performed as an inpatient service, requiring patients to stay in the hospital for up to 60 days.
At UCLA Health, however, unique staff expertise, coupled with outstanding capabilities in pharmacy, transfusion and supportive-care services, has enabled the opening of an Outpatient Stem Cell Transplantation Program that allows patients undergoing autologous stem cell transplantation and nonmyeloablative allogeneic stem cell transplantation to undergo treatment in an outpatient setting.
Patients and their caregivers are now able to receive hospital-level care and treatment in the UCLA Outpatient Stem Cell Transplantation clinic, which is adjacent to the Ronald Reagan UCLA Medical Center. In addition to the conveniences afforded by an outpatient setting, this approach also reduces a patient's risk of infection and substantially improves quality of life during the transplant procedure.
Adult Stem Cell Transplant Program (310) 206-6909
Pediatric Bone Marrow Transplant Program (310) 825-6708
An allogeneic stem cell transplant is a procedure in which bone marrow, peripheral blood or cord blood cells from a healthy donor are transplanted into patients suffering from cancer or disorders of the blood or immune system. In an autologous stem cell transplant, a patient's peripheral blood cells or bone marrow is transplanted back into the patient, in combination with high-dose chemotherapy or radiotherapy, as a means of eliminating cancer. Stem cell transplantation can be a curative therapy for many diseases, including leukemia, lymphoma, multiple myeloma, and hereditary blood, metabolic and immune diseases.
Visit our Health Library to learn more: Stem Cell Transplantation »
The United Network for Organ Sharing (UNOS) provides a toll-free patient services lines to help transplant candidates, recipients, and family members understand organ allocation practices and transplantation data. You may also call this number to discuss problems you may be experiencing with your transplant center or the transplantation system in general. The toll-free patient services line number is 1-888-894-6361